An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death
Active, not recruitingOBSERVATIONAL
Enrollment
589
Participants
Timeline
Start Date
August 1, 2024
Primary Completion Date
July 31, 2027
Study Completion Date
July 31, 2028
Conditions
HCM - Hypertrophic CardiomyopathyS-ICD System (implantable Defibrillator)
Trial Locations (1)
100037
Fuwai hospital, Beijing
All Listed Sponsors
lead
China National Center for Cardiovascular Diseases
OTHER_GOV
NCT06604169 - An Observational Study of Subcutaneous Implantable Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy At High Risk of Sudden Cardiac Death | Biotech Hunter | Biotech Hunter